"We see use of AI-generated cancer maps in the decision-making process of understanding who is the right patient for what therapy, as well as planning out the specific therapy," says Shyam Natarajan, ...

"I think the fact that we're having these conversations, that they are being talked about at national meetings, and that we are bringing the patient voice into this is hugely important," says Mary W.

"Often, we can do flexible cystoscopies for difficult Foley placements, or if we need to remove an indwelling stent at the bedside, I can assist with those things," says Emily Sopko, CNP. In this ...

“The technology is there, the experience is there now, and it's bringing it all together to lead to better outcomes [and a] shorter hospital stay,” says Kevin C. Zorn, MD, FRCSC, FACS. In this video, ...

"The urgency to increase awareness about prostate cancer is underscored by our most recent data and analysis," says William L. Dahut, MD. The American Cancer Society (ACS) has announced the launch of ...

"We found that the performance of Unfold AI was actually an AUC of .89," says Shyam Natarajan, PhD. In this video, Shyam Natarajan, PhD, describes the background and notable findings from the BJUI ...

The company expects the device to become available for US patients with pelvic organ prolapse in September 2024. ConTIPI Medical has announced a partnership with EVERSANA to support the US commercial ...

“Our study reveals potential differences in tolerance and effectiveness of AR inhibitors in practice, which can help clinicians and patients with treatment decisions," says Daniel J. George, MD.

"I like working alongside the residents, because they've taught me pretty much everything that I know about urology," says Emily Sopko, CNP. In this video, Emily Sopko, CNP, shares how she ...

"From the perspective of lifestyle medicine, what is most important is what the patient is most motivated to work on in the here and now," says Stacy Loeb, MD, MSc, PhD (Hon). “Thriving in Urology” is ...

“It's still relatively early, but this study in close to 1000 patients validated this algorithm, and it's now being studied prospectively as well,” says Yair Lotan, MD. In this interview, Yair Lotan, ...

“So, I think we have to be conscious that when we're developing these tools that we're inclusive,” says Yair Lotan, MD. In this interview, Yair Lotan, MD, shares ethical considerations for the ...